Congratulations to Associate Professor of Medicine, Ying Maggie Chen, MD, PhD, WashU Nephrology, who received a four-year, $1.15M VA Merit Award from the U.S. Department of Veterans Affairs. The funding will support her research on therapeutic targeting of mitochondria in uromodulin-associated chronic kidney disease (CKD). The $1.15M grant award includes the $750,000 grant (direct costs) […]
Tag: creld2
Patent Issued for Urinary Biomarkers for ER Stress-Mediated Kidney Disease
A U.S. patent was issued on 12/18/2018 to Division of Nephrology faculty member Ying (Maggie) Chen, MD, PhD, and co-inventor Yeawon Kim for their discovery of noninvasive biomarkers that have the potential to help diagnose certain human kidney diseases in their earliest stages of development. The patent is based on their research published in JCI […]
Broad Clinical Applications for CRELD2 as an ER Stress Biomarker
Thanks to a new study headed by Ying Maggie Chen, MD, PhD, it may soon be possible to diagnose certain human kidney diseases in their earliest stages of development using a noninvasive biomarker of endoplasmic reticulum (ER) stress. The study, Elevated Urinary CRELD2 is Associated with Endoplasmic Reticulum Stress-mediated Kidney Disease, was published online in […]